Sign in

CIK 0001802768 · Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
(212) 883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
  1. 4 Planned sale EVP & CFO sold 34,791 shares at $45.32 ($1,576,606)
  2. 4 Grant or award CEO, Chairman of the Board acquired 157,828 shares (grant or award)
  3. 4 Grant or award EVP & CFO acquired 26,626 shares (grant or award)
  4. 4 Grant or award EVP & Vice Chairman acquired 26,626 shares (grant or award)
  5. 4 Grant or award EVP, Research & Investments acquired 19,970 shares (grant or award)
  6. 4 Planned sale EVP & CFO sold 243,541 shares at an average $42.54 ($10,360,814)
  7. 4 Planned sale EVP, Research & Investments sold 20,000 shares at $41.09 ($821,810)
  8. 4 Planned sale EVP, Research & Investments sold 20,000 shares at $40.26 ($805,110)
  9. 4 Planned sale EVP & CFO sold 69,582 shares at $39.35 ($2,737,940)
  10. 4 Planned sale EVP, Research & Investments sold 20,000 shares at $39.52 ($790,346)
  11. 4 Planned sale EVP, Research & Investments sold 20,000 shares at $40.78 ($815,634)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Planned sale EVP & CFO sold 69,582 shares at $38.42 ($2,673,041)
  14. 4 Planned sale EVP, Research & Investments sold 20,000 shares at $38.48 ($769,650)
  15. 4 Grant or award Director acquired 967 shares (grant or award)
  16. 4 Planned sale EVP, Research & Investments sold 20,000 shares at $39.32 ($786,380)
  17. 4 Planned sale EVP, Research & Investments sold 20,000 shares at $38.38 ($767,582)
  18. 4 Planned sale EVP, Investments & CLO sold 110,000 shares at an average $38.55 ($4,240,333)
  19. 4 Planned sale EVP, Research & Investments sold 20,000 shares at $38.32 ($766,420)
  20. 4 Planned sale EVP & CFO sold 69,582 shares at $38.36 ($2,669,172)

Page 3 of 18 · 342 filings